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Qingliang Wang, MD,b Wencheng Jian, MD,b Zhanmin Wang, MD,a and Sanyuan Hu, MD,a
Jinan, People’s Republic of China
Objective: Superior mesenteric artery (SMA) aneurysms are rare but life-threatening entities. This study summarizes our
experience in providing therapeutic management for true aneurysms of the SMA.
Methods: Between February 1998 andMarch 2010, 10 patients were diagnosed with true SMA aneurysms in our hospital.
Medical data for demographics, clinical presentation, diagnosis, aneurysm characteristics, treatment modalities, out-
comes, and follow-up were retrospectively analyzed.
Results:Ten patients (six women, four men) were enrolled with a mean age of 56.7 years (range, 42-69 years). One patient
(10%) had aneurysm rupture and presented with abdominal pain, and seven (70%) were asymptomatic. The size of
nonruptured aneurysms ranged from 1.2 to 8.0 cm (mean, 3.5 cm). Of 10 patients, five received endovascular stent graft
repair, two were treated surgically, two were observed, and one with aneurysm rupture died of hemorrhagic shock before
surgery. The two surgical patients underwent SMA reconstruction after aneurysmectomy, and segmental bowel resection
was performed in one patient after reconstruction. The overall mortality rate was 10%. Postoperative gastroparesis was
identified in one patient (14.3%). Mean operation time was 3.6 hours in the surgical group and 1.3 hours in the
endovascular group. Mean postoperative hospital stay for the two groups was 20.0 days and 2.2 days, respectively. Mean
follow-up was 30.9months (range, 3-72months). Endoleak was found in one patient 3months after endovascular repair.
Conclusion: True SMA aneurysms are uncommon entities with definite rupture risk and mortality. Compared with
surgical intervention, endovascular stent graft placement is associated with less trauma and rapid recovery. It may be a
promising alternative to surgical intervention. The most appropriate treatment depends on the characteristics of the
lesion and the condition of the patient. ( J Vasc Surg 2011;53:1619-24.)
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aSuperior mesenteric artery (SMA) aneurysms are rare
clinical entities. They account for 6.9% of all visceral artery
aneurysms (VAAs).1 With the increasing use of cross-
sectional imaging, SMA aneurysms have been detected
increasingly.1,2 They are clinically important because of
severe complications, including embolism and rupture,
which can result in acute mesenteric ischemia and fatal
massive hemorrhage. Approximately 38% of SMA aneu-
rysms were ruptured at presentation.1 The mortality of
SMA aneurysms reaches 40% to 60%.3
To our knowledge, most literature had one to two
patients as case reports.4-7 In this study, the authors aimed
to describe our experience in 10 patients to provide thera-
peutic management for true aneurysms of the SMA, which
included surgical and endovascular techniques. Endovascu-
lar treatment of VAAs in the literature mainly focused on
coil embolization of splenic and hepatic artery aneu-
rysms.8-11 However, endovascular therapy in the current
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ETHODS
Patients. A retrospective analysis was performed of
atients with true aneurysms of the SMA who presented to
ur hospital from February 1998 to March 2010. All
atients included for analysis had a diagnosis of SMA
neurysms with imaging or pathologic evidences. Patients
ith true aneurysms (Fig 1) were defined as those who had
istologic evidences or imaging findings of spherical or
usiform aneurysms of the main SMA trunk with no history
f pancreatitis, abdominal trauma, or surgery. The study
xcluded patients with pseudoaneurysms or isolated dissec-
ion of the SMA. Also excluded were patients with SMA
neurysms in the setting of aortic aneurysms or aortic
issection. This is a retrospective study, thus, management
f these patients was not based on a specific research
rotocol. Open surgery was the conventional treatment at
he early stage due to unavailability of endovascular exper-
ise. Then, management depended on surgeon judgment.
edical data for demographics, clinical presentation, diag-
osis, aneurysm characteristics, treatment modalities, out-
omes, and follow-up were retrospectively analyzed.
herapeutic management
Observation. Asymptomatic patients with small aneu-
ysms (1.2 cm and 1.4 cm in size) were observed. The
neurysms were monitored by color duplex ultrasound or
omputed tomography (CT) scan.
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June 20111620 Jiang et alSurgical intervention. It was performed under gen-
eral anesthesia through a median abdominal incision. After
the abdominal cavity was opened, the aneurysm was ob-
served. Many small arteries originated from the aneurysm.
There were severe adhesions between the aneurysm and
surrounding tissue. The proximal and distal aneurysm
necks were dissected and encircled with two vascular loops.
To test the response of the bowel to SMA ligation, two
necks of the aneurysm were clamped temporarily. Ischemic
changes were observed on segmental small bowel 10 to 15
minutes later. Two clamps were removed. Reconstruction
of the SMA was considered.
In one patient with an 8-cm aneurysm, the distal aneu-
rysm neck was cut and anastomosed to the abdominal aorta
(end to side). Then, the proximal neck was cut and ligated.
Several arteries originating from the aneurysmwere ligated.
The aneurysm was isolated from surrounding tissue and
removed. Severe ischemia was identified on the fourth
portion of the duodenum and the 80-cm-long proximal
jejunum. The ischemic bowel was resected, and an end-to-
end duodenojejunal anastomosis was performed.
In the other patient with a 5-cm aneurysm, a 6-cm
segment of saphenous vein was taken from the right groin.
Proximal and distal aneurysm necks were clamped tempo-
rarily. Several arteries originating from the aneurysm were
cut and ligated. After the aneurysm was opened, contents
were evacuated. The aneurysmal wall was resected, and
the bleeding sites were suture ligated. The SMA was
reconstructed with a saphenous vein interposition graft.
No ischemia was identified on the small bowel after
reconstruction.
Endovascular intervention. Endovascular stent graft
Fig 1. Preoperative computed tomography (CT) angiogram
shows an 8-cm calcified aneurysm arising from the superior mes-
enteric artery (SMA).placement was performed under local anesthesia. Written rnformed consent was obtained from every patient before
urgery. The femoral artery was punctured first, and the
MAwas catheterized with a Cobra catheter. Heparin (100
/kg) was administered intravenously. Angiography
howed an SMA aneurysm (Fig 2, A). Several branches of
he SMA originated from proximal and distal aneurysm
ecks. No obvious branches originated from the aneurysm.
he Cobra catheter was reserved at the SMA orifice for
ngiography in real time. The diameter and length of
ig 2. A, Selective superior mesenteric artery (SMA) angiogram
hows a 3.2-cm aneurysm on the main trunk. B, Completion
ngiogram shows complete exclusion of the aneurysm with no
ndoleak.equired stent grafts were measured from preoperative CT
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Volume 53, Number 6 Jiang et al 1621scans or intraoperative angiography. The stent graft was
usually 1 mm larger in diameter than the proximal aneu-
rysm neck. It covered distal and proximal necks at least 1
cm, respectively. Then, the left brachial artery was punc-
tured and a 0.035-inch, 150-cm guidewire was introduced
to the SMA. A Vert catheter was negotiated over the
guidewire into the distal aneurysm neck. The guidewire was
exchanged for a 0.035-inch, 260-cm stiff guidewire. The
deliver system was advanced over the stiff guidewire. Then,
angiography was performed to locate the stent graft via the
Cobra catheter. After that, a (6-8  40-80 mm) Fluency
covered stent (CR Bard Inc, Murray Hill, NJ) was de-
ployed. Completion angiography showed patency of the
stent graft and complete exclusion of the aneurysm without
endoleak (Fig 2, B). At most, three jejunoileal branches of
the SMA were covered by the stent graft. Patients were
observed for potential bowel ischemia postoperatively ac-
cording to clinical manifestations and biochemical testing.
In general, only one arterial access (brachial, axillary, or
femoral) was used in endovascular stent graft repair for true
or false SMA aneurysms.7,12-18 In our study, both brachial
and femoral accesses were used. First, the stent graft was
introduced via the brachial artery. It is preferred to the
femoral artery approach due to an acute angle between the
SMA and the aorta.14,16 Second, a Cobra catheter was
reserved at the SMA orifice via the femoral artery. There-
fore, angiography can be performed in real time. Especially,
the SMA has a certain range of motion in the abdomen.
The position of the SMA would be changed after introduc-
tion of the deliver system. Angiography before deployment
via the Cobra catheter can locate the stent graft more
accurately and avoid covering extra branch arteries. In our
experience, the method also facilitated the procedure.
Follow-up. Patients under observation were followed
up semiannually. Postoperative patients were followed at 1,
3, and 6 months after hospital discharge, and then annually
to evaluate patency of stent grafts or SMA. Ultrasonogra-
phy or CT angiography was performed during follow-up.
Clopidogrel, 75 mg/d, was given for 3 to 6 months after
endovascular treatment. Aspirin, 100 mg/d, was taken as a
lifelong medication for all postoperative patients.
RESULTS
Patient demographics. Of 22 patients with a diagno-
sis of SMA aneurysms, 10 patients (45.5%) were identified
with true SMA aneurysms. Of these 10 patients, six (60%)
were women and four (40%) were men. Mean age at
presentation was 56.7 years (range, 42-69 years). Three
patients (30%) had a history of hypertension. One patient
suffered from varicosity in the left lower extremity. No
aneurysms were found in other arteries. No history of
bacterial endocarditis, vasculitis, or collagen vascular dis-
eases was identified in these patients.
Clinical presentation and diagnosis. Seven patients
(70%) were asymptomatic. One patient (10%) had aneu-
rysm rupture and suffered severe abdominal pain with
unstable hemodynamics at presentation. One patient pre-
sented with chronic obstructive symptoms of the duode- ium. One patient complained of intermittent abdominal
iscomfort. Physical examination showed a pulsatile ab-
ominal mass in one patient.
Seven asymptomatic patients (70%) were diagnosed
ncidentally by ultrasonography during medical check-ups.
he patient with a ruptured aneurysmwas diagnosed by CT
ngiography. Two symptomatic patients were initially di-
gnosed by conventional CT scan. In the study, CT an-
iography was performed in all patients to establish the
iagnosis. Seven patients (70%) underwent selective SMA
ngiography before surgical intervention or during endo-
ascular repair. Two patients (20%) were confirmed by
athologic examination.
Aneurysm characteristics. The size of the ruptured
neurysm was not recorded accurately. Mean size of non-
uptured aneurysms was 3.5 cm (range, 1.2-8.0 cm). The
istance between the aneurysm and the SMA orifice ranged
rom 2.0 to 6.2 cm (mean, 3.7 cm). Nine patients (90%)
ere found to have a solitary aneurysm on themain trunk of
he SMA. One patient (10%) had a large aneurysm on the
ain trunk and several small ones in distal branches. Celiac
xis stenosis was noted in one patient. Four patients (40%)
ad calcified SMA aneurysms. Mural thrombus was identi-
ed in two aneurysms. The etiology was demonstrated to
e atherosclerosis by histologic examination in two patients
20%). Other patients (80%) had an unknown etiology for
neurysmal degeneration.
Treatment methods and outcomes. Of 10 patients,
ve underwent endovascular stent graft placement, two
ere treated with open surgery, two were under observa-
ion, and one who had aneurysm rupture died of hemor-
hagic shock before surgery. Surgical intervention included
neurysmectomy with saphenous vein interposition graft
n  1) and aneurysmectomy with transposition of the
istal SMA trunk onto the aorta and partial bowel resection
ith duodenojejunal anastomosis (n  1). The overall
ortality was 10%. Postoperative gastroparesis was identi-
ed in the patient with an 8-cm aneurysm (morbidity,
4.3%). Recovery of gastrointestinal function was achieved
y conservative therapy 29 days after surgery. Mean oper-
tion time was 3.6 hours (range, 3.0-4.3 hours) in the
urgical group and 1.3 hours (range, 1.0-1.7 hours) in the
ndovascular group. Mean postoperative hospital stay in
wo groups was 20.0 days (range, 8-32 days) and 2.2 days
range, 2-3 days), respectively.
Follow-up. The patients who survived to discharge
ere alive with a mean follow-up of 30.9 months (range,
-72 months). No discomfort was complained of in these
atients. No obvious growth was noted in two observed
atients during follow-up (range, 12-36 months). The
MA reconstructions were patent in the surgical group (Fig
, A). The stent grafts were patent in the endovascular
roup without in-stent stenosis. Endoleak was found in one
atient at 3 months after endovascular repair (Fig 3, B).
he cause of endoleak could not be identified from CT
mages. The patient has been undergoing close follow-up.
4
p
i
t
m
r
p
c
(
t
c
t
t
w
c
S
r
T
s
m
o
i
a
p
o
o
r
i
S
s
T
t
r
t
c
a
g
p
f
t
n
p
a
o
s
u
d
a
r
i
a
i
o
JOURNAL OF VASCULAR SURGERY
June 20111622 Jiang et alDISCUSSION
In the study, all patients were 40 years old. Almost
60% of the patients were women. Most aneurysms were5
cm in size and located in the first 5 cm of the SMA in
current and previous studies.1,19 It was considered that
most patients were symptomatic, including abdominal pain
Fig 3. A, Computed tomography (CT) angiogram at 12-month
follow-up shows the patent superior mesenteric artery (SMA)
reconstruction (large arrow) in the patient who had transposition
of the distal SMA trunk onto the aorta. The patient still had SMA
branch aneurysms (small arrows). B, CT angiogram at 3-month
follow-up shows endoleak (arrow) after endovascular stent graft
repair.and gastrointestinal bleed.3,20-22 However, approximately f8% of patients were asymptomatic in Stone’s study.1 The
roportion reached 70% in this study. They were identified
ncidentally during check-ups. More detection of asymp-
omatic patients may be related to an increased use of
odern imaging techniques.1,2,23,24
The etiology of true aneurysms remains elusive. Bacte-
ial infection was considered the most common cause in the
ast. A recent study indicated atherosclerosis was the most
ommon pathologic finding, and only 4.8% of patients
1/21) had an infectious etiology.1 However, many au-
hors believed atherosclerosis may be a secondary pro-
ess.1,25 In this study, atherosclerosis was demonstrated in
wo patients (20%) by histologic examination. No infec-
ious etiology was identified, and etiology in most patients
as still unknown. Fewer infective SMA aneurysms may be
oncerned with widespread antibiotic usage.26
Aneurysm rupture is themost common complication of
MA aneurysms, which is associated with a high mortality
ate. Almost 22% of patients require emergency treatment.
hemortality of SMA aneurysms is 40% to 60%.3 In Stone’s
eries, the rupture rate was 38.1% at presentation, and the
ortality was 37.5% for ruptured aneurysms.1 In the study,
ne patient (10%) had aneurysm rupture. She was admitted
n shock and died before surgery. Although there are only
small number of patients with SMA aneurysms at
resent, it seems the mortality rate is higher than that of
ther VAAs.9,27-32 More attention should be paid to the
bserved patients with SMA aneurysms.
Treatment of choice is resection of aneurysms and
econstruction of the SMA. Surgical approaches mainly
nclude ligation, aneurysmorrhaphy, and aneurysmectomy.
imple ligation was the most commonmethod.3 In Stone’s
tudy, 62.5% of operative patients were treated by ligation.1
his procedure is acceptable sometimes because of poten-
ial collateral circulation from the celiac artery or the infe-
ior mesenteric artery to the SMA.1,7,33,34 In this study,
wo surgical patients underwent aneurysmectomy with re-
onstruction of the SMA, including transposition onto the
bdominal aorta (n  1) and saphenous vein interposition
raft (n 1). Compared with preoperative SMA angiogra-
hy, the authors found many more branches originating
rom the aneurysms during surgical procedures. It is likely
hat SMA angiography could not show all branches origi-
ating from aneurysms. Patients should be observed for
otential bowel ischemia after endovascular repair.
Compared with surgical treatment, endovascular ther-
py remains a new technique for true SMA aneurysms. To
ur knowledge, few patients were treated by endovascular
tent graft repair.7,12 In the present study, five patients
nderwent endovascular stent graft placement. During en-
ovascular treatment, it is necessary to evaluate the branch
rteries, which originated from proximal and distal aneu-
ysm necks and the aneurysm. If they are covered, it may
mpair blood supply to the intestine. InMendonça’s report,
t least three jejunal branches were covered without bowel
schemia.7 In this series, one to three jejunoileal branches
riginating from aneurysm necks were covered unevent-
ully. This may be related to good collateral circula-
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Volume 53, Number 6 Jiang et al 1623tion.1,33,34 Many branches were identified in two surgical
patients. In view of potential bowel ischemia after stent
graft placement, they were treated surgically. During the
procedure, bowel ischemia was confirmed in one patient
after SMA reconstruction due to ligation of many small
branches that arose from the aneurysm.
Endovascular stent graft repair for SMA aneurysms is
not exempt from complications. Szopin´ski17 andWallace18
have reported endoleak after endovascular repair, which
resulted from retrograde filling of collateral vessels. In our
study, endoleak was identified in one patient with a 3.2-cm
aneurysm at 3-month follow-up, which was not detected
during intraoperative angiography. The fat patient was
asymptomatic and most of the aneurysm lumen was throm-
bosed. It would be difficult to treat it with endovascular or
percutaneous embolization.17,18 Thus, the patient was ob-
served closely and the extent of the endoleak was moni-
tored. We considered whether we could place a stent graft
into the SMA and embolize the aneurysm lumen with coils
in one procedure. During our procedure, a guidewire can
be reserved in the aneurysm lumen via the Cobra catheter
after angiography is performed to locate the stent graft.
After the endograft is deployed, the Cobra catheter can be
advanced into the aneurysm lumen over the guidewire.
Then, the lumen can be embolized via the Cobra catheter.
We have used a combination of stent graft and coil embo-
lization to treat an anomalous splenic artery aneurysm
successfully.
The effect of surgical intervention is definite, while
short- and long-term results of endovascular repair are still
unclear. It seems the endovascular group had shorter oper-
ative time and hospital stay than the surgical group. In our
experience, endovascular treatment is associated with less
trauma and rapid recovery. It may be a promising alterna-
tive to surgical intervention. Compared with open surgery,
endovascular repair may be safer and preferred in patients
with severe cardiac or pulmonary diseases. However, it
cannot completely replace surgical intervention. Endovas-
cular stent graft repair may be unsuitable for SMA aneu-
rysms in the following conditions. (1) Many arteries origi-
nate from the proximal and distal aneurysm necks or the
aneurysm. Coverage of these vessels may cause bowel isch-
emia. (2) Giant aneurysms do not have adequate landing
zones, and the stability of the stent graft is unclear in a giant
lumen. In our series, one patient had a giant aneurysm
which was 8 cm in diameter. It is difficult to guarantee the
stability of the endograft in view of short landing zones and
high blood flow in the SMA. (3) The aneurysms have an
infectious etiology. Thus, treatment should depend on the
comorbidity conditions of the patient and the characteris-
tics of the lesion.
CONCLUSION
True aneurysms of the SMA are rare clinical entities
with definite rupture risk and mortality. Compared with
surgical intervention, endovascular stent graft repair is as-
sociated with less trauma and rapid recovery. It may be a
promising alternative to surgical intervention. The choicef the most appropriate treatment depends on the charac-
eristics of the lesion and the states of the patient.
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